Position in JNJ
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$388,415
+$55,433 QoQ
Shares Held
1,589
-1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Jackson Hole Capital Partners, LLC holds $25,097,540 across 8 Drug Manufacturers - General names. JNJ ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
35,906 | $7,809,195 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,790 | $7,553,009 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
33,305 | $4,641,717 | |
| 4 | PFE |
Pfizer Inc
|
120,319 | $3,378,557 | |
| 5 | LLY |
ELI LILLY & Co
|
911 | $837,910 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
1,589 | $388,415 | |
| 7 | AMGN |
Amgen Inc
|
727 | $255,794 | |
| 8 | NVS |
Novartis AG
|
1,525 | $232,943 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $388,415 | 1,589 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $332,982 | 1,609 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $353,225 | 1,905 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $346,131 | 2,266 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $370,984 | 2,237 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $322,647 | 2,231 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $361,555 | 2,231 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $326,082 | 2,231 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $367,158 | 2,321 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $379,624 | 2,422 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $377,226 | 2,422 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $404,199 | 2,442 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $378,510 | 2,442 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $408,414 | 2,312 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $377,688 | 2,312 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $406,852 | 2,292 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $389,374 | 2,197 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $355,483 | 2,078 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $384,047 | 2,378 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $445,621 | 2,705 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $427,967 | 2,604 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $406,355 | 2,582 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $384,408 | 2,582 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $363,106 | 2,582 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $295,698 | 2,255 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||